MicroRNA 与肿瘤的相关研究进展

微小RNA(microRNAs,miRNA)是一类22个核苷酸左右的非编码调控RNA。可以通过切割mRNA或者是抑制翻译两种机制,在转录后水平发挥调控生物生长发育的重要作用。目前的研究已经发现microRNA参与调控发育、细胞分化、细胞凋亡等多种生理过程。目前已证实miRNA参与肿瘤发生和进展,miRNA表达谱是肿瘤诊断和预后的指标,miRNA突变、缺失或表达水平的异常与人类肿瘤密切相关,它发挥类似于癌基因或抑癌基因的作用,参与肿瘤细胞的增殖、分化和细胞凋亡过程。本文就miRNA在肿瘤发生发展以及诊断治疗方面的研究进展作一综述。     

MicroRNA与细胞分化及发育

microRNA（miRNA）能调控基因表达是近年来在动植物体内发现的一种新的调控基因表达的方式.在动物体内,通过基因敲除方法所进行的研究表明了miRNA参与了胚胎早期发育、神经发育、肌肉发育和淋巴细胞发育等动物发育的各个方面.这些研究提示,miRNA是动物发育过程中的重要调控因子,而且与很多人类的疾病相关.本文介绍了近期miRNA在细胞分化及发育中的研究进展.     

MicroRNA在脂肪细胞分化中的调节作用

MicroRNA(miRNA)是一类内源性、短小、大小为～22核苷酸的单链非编码RNA.miRNA广泛分布于真核细胞内,能够通过与靶mRNA3'末端非翻译区(3'-untranslated region,3'UTR)特异性结合来降解或抑制靶mRNA的翻译,从而对基因进行转录后基因表达的调控.miRNA不仅调控生物体的生长和发育过程,而且参与调控多种生理学和病理学过程,如细胞分化、细胞增殖、胰岛素的分泌、脂肪代谢以及肿瘤的形成.研究表明miRNA在肿瘤、糖尿病、代谢等多种疾病中发挥着重要的作用.本文对miRNA在脂肪细胞分化及脂类代谢中的调节作用进行综述.     

miRNA调控昆虫与病毒互作的研究进展

miRNA是一类重要的非编码小分子RNA,可在转录后水平调控基因表达,参与并调控机体的生长发育、细胞分化、细胞凋亡、抗病毒、激素分泌、神经系统等重要生物过程。本文介绍了miRNA的合成途径及其生物学功能,并重点阐述miRNA在昆虫宿主与病毒互作中的调控作用:通过mRNA剪切或抑制靶标蛋白的翻译负调控靶标基因,实现基因沉默,调控约50%的蛋白质编码基因的表达,许多miRNA已被发现在人体和植物中参与调控病毒的复制侵染,因此也有可能控制害虫对病毒抗性的产生,恢复病毒对害虫的防控作用。最近有研究将害虫特异的miRNA转入植物,干扰昆虫蜕皮过程导致幼虫的死亡,作为Bt转基因作物的替代,成为抗虫基因工程的新选择。研究miRNA在昆虫对病毒抗性产生中的作用,将为昆虫抗病毒机制的研究提供新的思路,为害虫生物防治措施的应用及改进提供理论参考。     

MicroRNA对多细胞动物复杂性进化的影响

MicroRNA(miRNA)是一种长度约为22个碱基的非编码单链小分子RNA。作为一类重要的转录后基因表达调控因子,miRNA参与了广泛的生物学过程,如发育时程调控、细胞分化、凋亡、肿瘤以及病毒抵抗等。然而,除了在个体发生过程中的重要功能外,越来越多的研究表明,miRNA在系统发生中也扮演着关键的角色。基因表达模式的不同被广泛地认为是物种内和物种间表型差异的根源,动物物种间miRNA的保守性和多样性研究提示miRNA对物种间表型差异以及动物进化起着重要的作用。文章介绍了miRNA产生过程和作用机制,重点探讨了miRNA在动物进化过程中的作用,从miRNA的进化速度、miRNA表达的时空特异性、miRNA作用靶位点变异以及miRNA基因的扩增与丢失4个方面论述miRNA介导的基因调控网络对多细胞动物发育复杂性进化的影响,推测miRNA在多细胞动物进化过程中驱动了复杂性的增加。     

miRNA调控药用植物生长发育和次生代谢

microRNA(miRNA)作为一类内源性的短链非编码RNA,广泛存在于真核细胞中,主要通过对转录本剪切和抑制翻译等方式,参与转录后基因的表达调控。近年来研究表明,多种药用植物中鉴定出大量的miRNA。这些miRNA对药用植物的生长发育和次生代谢产物合成具有调控功能。次生代谢产物是药用植物的主要有效成分,研究miRNA对药用植物次生代谢过程的调控作用具有十分重要的意义。本文综述了miRNA在植物中的产生途径、作用方式和体内功能,在此基础上重点介绍了miRNA对药用植物生长发育和次生代谢产物生物合成的调控作用,并对药用植物miRNA的研究进行了展望,以期为提高药用植物产量,高效获得药用植物有效成分以及临床应用开拓新的思路。     

小分子RNA在植物激素信号通路中的调控功能

植物激素是调控植物生长发育的信号分子。近年来的研究发现,小分子RNA作为基因表达调控网络的组分,参与植物激素信号途径,在植物生长发育和胁迫反应方面发挥重要作用。本文综述了miRNA和次级siRNA(Short interfering RNAs)介导的基因调控与植物激素信号通路相互作用的研究进展,主要包括生长素、赤霉素、油菜素内酯和脱落酸途径涉及的miRNA及其功能,并对不同发育过程中miRNA参与的不同激素信号通路的交叉和互作进行了讨论。     

MicroRNA 在皮肤创伤愈合中的作用

皮肤创伤愈合过程是一个复杂而连续的过程,这一过程需要多种细胞、多种因子的参与,涉及细胞增殖、细胞分化、细胞运动、细胞黏附等多个细胞生物学过程。 MicroRNA（ miRNA）是一类高度保守的非编码RNA,它通过靶向结合信使RNA（ mRNA）并使其降解或抑制其翻译,实现转录后基因表达调控。 miRNA作为基因表达的重要调控分子,几乎参与了机体所有的生理和病理过程。除了在皮肤发育中发挥重要的作用,还参与多种皮肤病、皮肤癌和皮肤创伤愈合过程的调节。主要总结了miRNA调控皮肤创伤愈合的研究进展。     

植物激素相关microRNA研究进展

microRNA（miRNA）是22nt左右的非编码RNA,主要在转录后水平调节基因的活性。miRNA通过与靶基因的互补位点结合从而降解靶基因mRNA或抑制其翻译。近年的研究发现,miRNA在植物生长发育中发挥着重要的调控作用。目前已知一些miRNA参与植物激素信号途径的切入点,这为我们了解miRNA和植物激素在植物发育中的作用提供了新思路。本文综述了miRNA参与植物激素信号应答及生物合成的研究进展,并对一些miINA在植物激素信号应答中可能的作用进行了讨论。     

miRNA在调控皮肤和毛囊发育中的作用

表皮发生和毛囊的周期性再生涉及一系列基因的激活和沉默。近年来的研究表明, miRNA的表达谱在表皮和毛囊组织中存在组织特异性, 在毛囊周期性发育中存在阶段特异性。大量miRNA参与表皮和毛囊的发生, 色素的沉着以及毛囊的周期性发育过程, 不同类型细胞中的miRNA通过与信号通路和调控因子相互作用形成了一个全方位、多层次的网络调控系统。文章综述了miRNA调控表皮内稳态和毛囊周期性发育的一些研究 进展, 旨在丰富miRNA参与的基因调控网路的研究, 进而为人工调控miRNA进行疾病治疗和分子育种提供 帮助。     

Surface changes in differentiating Friend erythroleukemic cells in culture.

The sensitivity to agglutination by several plant lectins has been studied during the induced erythroid differentiation of Friend erythroleukemic cells in culture. In addition, the number of lectin receptors on the cell has been measured. It is shown that early during the differentiation, there is an increase in agglutinability while the receptor density remains constant. In the later phase of the differentiation process, the cells lose their sensitivity to agglutination while the receptor number and density increases. These changes were not observed on nonerythroid mastocytoma culture cells. Two nondifferentiating variants of the FL cells were shown to have altered sensitivities to agglutination by ConA.     

Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation.

We have previously shown that a serum protein, termed differentiation reversal factor (DRF), is responsible for neurite retraction in differentiated cultures of an adenovirus 12 (Ad12) transformed human retinoblast cell line. Data is presented here to show that DRF is identical to the serine protease prothrombin. Both proteins have been immunoprecipitated using an antibody raised against purified prothrombin and have been shown to hydrolyse a specific thrombin substrate only after activation by the snake venom ecarin. Following addition to Ad12 HER 10 cells, which had previously been differentiated by culture in the presence of 2 mM dibutyryl cAMP in serum-free medium, thrombin and prothrombin caused half-maximal retraction of neurites at concentrations of 0.5 ng/ml and 20 ng/ml respectively. Interestingly, activation of prothrombin was shown to be unnecessary for biological activity. Using the inhibitor di-isopropylfluorophosphate (DIP), we have shown that abrogation of the proteolytic activity of thrombin also results in a loss (greater than 2000 fold) of differentiation reversal activity. Thrombin and its zymogen both stimulated the mitosis of differentiated Ad12 HER 10 cells to a similar extent. In addition, differentiation reversal was highly specific since, at physiologically significant concentrations, closely related serine proteases did not cause neurite retraction. Prothrombin and thrombin also reversed morphological differentiation in the SK-N-SH neuroblastoma cell line and in heterogeneous cultures of cells from various regions in the human foetal brain.     

Terminal Myeloid Differentiation is Uncoupled from Cell Cycle Arrest

It has been assumed that terminal myeloid differentiation and cell cycle arrest are coupled processes, and that prohibiting cell cycle arrest blocks differentiation. Previously we have shown that, using the murine M1 myeloid leukemic cell line, deregulated expression of the proto-oncogene c-myc results in cells that cannot be induced to undergo terminal differentiation and continued to proliferate. It has also been shown that ectopic expression of Egr-1 abrogated the c-Myc block in terminal myeloid differentiation, yet there was no accumulation of cells in the G0/G1 phase of the cell cycle. In this study we conclusively demonstrate that M1Myc/Egr-1 cells terminally differentiate while still actively cycling and synthesizing DNA, concluding that the terminal myeloid differentiation program is uncoupled from growth arrest. How deregulated expression/activation of proto-oncogenes that promote cell cycle progression interferes with differentiation and how differentiation is regulated independently of cell cycle control are discussed, as well as the implications with regard to differentiation therapy.     

Regulation of miR-34 Family in Neuronal Development

Differentiation of neural stem cells (NSC’s) to mature and functional neurons requires coordinated expression of mRNA, microRNAs (miRNAs) and regulatory proteins. Our earlier unbiased miRNA profiling studies have identified miR-200, miR-34 and miR-221/222 as maximally up-regulated miRNA families in differentiating PC12 cells and demonstrated the capability of miR-200 family in inducing neuronal differentiation (J. Neurochem, 2015, 133, 640–652). In present study, we have investigated role of miR-34 family in neuronal differentiation and identified P53 as mediator of nerve growth factor (NGF) induced miR-34a expression in differentiating PC12 cells. Our studies have shown that NGF induced miR-34a, arrests proliferating PC12 cells to G1 phase, which is pre-requisite for neuronal differentiation. Our studies have also shown that increased expression of miR-34a controls the P53 level in differentiated PC12 cells in feedback inhibition manner, which probably prevents differentiated cells from P53 induced apoptosis. Expression profiling of miR-34 family in different neuronal, non-neuronal and developing cells have identified differentiated and aged brain cells as richest source of miR-34, which also indicates that higher expression of miR-34 family helps in maintaining the mature neurons in non-proliferative stage. In conclusion, our studies have shown that miR-34 is brain enriched miRNA family, which up-regulates with neuronal maturation and brain ageing and co-operative regulation of P53 and miR-34a helps in neuronal differentiation by arresting cells in G1 phase.     

Neuronal and mesodermal differentiation of P19 embryonal carcinoma cells is characterized by expression of specific marker genes and modulated by activin and fibroblast growth factors

We have used the P19 embryonal carcinoma (EC) aggregation system as a model for early mouse development to study induction and modulation of mesodermal and neuronal differentiation. By studying the expression of marker genes for differentiated cells in this model we have shown that there is a good correlation between the differentiation direction induced in P19 EC aggregates and the expression of these genes. Expression of the neuronal gene midkine is exclusively upregulated when P19 EC cells are induced to form neurons while expression of early mesodermal genes such as Brachyury T, evx-1 , goosecoid and nodal is elevated after induction to the mesodermal pathway. In the present study we have further shown that activin A blocks the different directions of differentiation of P19 EC cells induced by retinoic acid (RA) in a dose-dependent way. To understand the mechanism behind this inhibitory action of activin A the expression of several RA-responsive genes, including the three RA receptor genes (RARα, RARβ and RARγ) was determined. Since activin has no clear effect on the expression and activity of the RAR it is very likely that this factor acts downstream of these receptors. In addition to activin, fibroblast growth factors (FGF) were shown to modulate P19 EC cell differentiation. However, in contrast to activin, FGF exclusively blocks the mesodermal differentiation of P19 EC cells by either 10⁻⁹mol/L RA or a factor produced by visceral endoderm-like cells (END-2 factor). The FGF effect is dose-independent. These results suggest an important function for RA and the END-2 factor in the induction and for activin and FGF in the modulation of specific differentiation processes in murine development.     

The prevention of adipose differentiation of 3T3-L1 cells caused by retinoic acid is elicited through retinoic acid receptor alpha

Retinoids, especially all-trans retinoic acid (RA), have been shown to inhibit the differentiation of preadipose cells. It is important to human health, especially to obesity, that the regulatory system for the differentiation of adipocytes is well defined. Previously, we have shown that retinoic acid receptor (RAR) γ2 gene expression is up-regulated by RA in 3T3-L1 preadipose cells. In this study, the RAR system was dissected and the RA-regulated function in 3T3-L1 cells was assigned to one given receptor. We used three synthetic retinoids; (1) Ro 41–5253, a selective RAR α antagonist, (2) Ch 55, an RAR α, β and γ agonist, and (3) Am 80, an RAR α and β agonist, which has less affinity to RAR γ. Ro 41–5253 reverted RA-induced inhibition of the differentiation of 3T3-L1 cells. However, there was no significant reversion in RA-induced RAR γ mRNA level by treatment with Ro 41–5253. In the case of RAR agonists, both Am 80 and Ch 55 strongly inhibited the differentiation of 3T3-L1 cells. However, Am 80 weakly increased RAR γ mRNA content less than did Ch 55. These findings suggest, that RAR α is involved in the prevention of adipose differentiation by RA in 3T3-L1 cells. Moreover, there seems no causal relationship between the prevention of adipose differentiation by RA and the up-regulation of RAR γ2 gene expression by RA in 3T3-L1 cells. We have shown the functional heterogeneity of RA action through different RARs in 3T3-L1 cells.     

Nanofiber-based polyethersulfone scaffold and efficient differentiation of human induced pluripotent stem cells into osteoblastic lineage

Human induced pluripotent stem cells (iPSCs) have been shown to have promising potential for regenerative medicine and tissue engineering applications. In the present study, osteogenic differentiation of human iPSCs was evaluated on polyethersulfone (PES) nanofibrous scaffold. According to the results, higher significant expressions of common osteogenic-related genes such as runx2, collagen type I, osteocalcin and osteonectin was observed in PES seeded human iPSCs compared with control. Alizarin red staining and alkaline phosphatase activity of differentiated iPSCs demonstrated significant osteoblastic differentiation potential of these cells. In this study biocompatibility of PES nanofibrous scaffold confirmed by flattened and spreading morphology of iPSCs under osteoblastic differentiation inductive culture. Taking together, nanofiber-based PES scaffold seeded iPSCs showed the highest capacity for differentiation into osteoblasts-like cells. These cells and PES scaffold were demonstrated to have great efficiency for treatment of bone damages and lesions.     

MicroRNA control of myelopoiesis and the differentiation block in acute myeloid leukaemia

In the relatively short period of time since their discovery, microRNAs have been shown to control many important cellular functions such as cell differentiation, growth, proliferation and apoptosis. In addition, microRNAs have been demonstrated as key drivers of many malignancies and can function as either tumour suppressors or oncogenes. The haematopoietic system is not outside the realm of microRNA control with microRNAs controlling aspects of stem cell and progenitor self-renewal and differentiation, with many, if not all, haematological disorders associated with aberrant microRNA expression and function. In this review, we focus on the current understanding of microRNA control of haematopoiesis and detail the evidence for the contribution and clinical relevance of aberrant microRNA function to the characteristic block of differentiation in acute myeloid leukaemia.     

Differentiation capabilities of human germ cell tumors

It is well known that human germ cell tumors are an excellent model to study not only differentiation capacity of tumor cells but also human normal somatic cell differentiation. A variety of polyclonal and monoclonal antibodies were developed against cell surface antigens of murine embryos and teratocarcinomas. Accumulated data has revealed that these antigens are sequentially expressed on embryonic cells in a well-programmed manner. They have also been shown to be useful markers to investigate somatic cell differentiation in fetal and adult tissue. In humans, however, little is known about the cellular differentiation mechanism in early embryos and whether they could be studied, i.e. whether they occur in human germ cell tumors. In present review, we discussed newly established monoclonal antibodies which were raised from human embryonal carcinoma cells. We have been studying differentiation capacity of human germ cell tumor cells by using these antibodies. Some of these antibodies clearly indicates their usefulness to specify the developmental stage of normal tissue.